How to Buy Elevance Health Stock
Elevance Health Inc
Elevance Health is a healthcare plan company located in Indiana, United States, which is part of the Healthcare sector, and is traded under the ticker ELV on the NYSE exchange.
Elevance Health stock last closed at $395.18, up 2.03% from the previous day, and has increased 5.9% in one year. It has underperformed other stocks in the Healthcare Plans industry by 0.09 percentage points. Elevance Health stock is currently +44.38% from its 52-week low of $273.71, and -7.45% from its 52-week high of $426.98.
There are currently 217.16M shares of ELV outstanding. The market cap of ELV is $85.82B. In the past 24 hours, 2.91M ELV shares were traded.
How to Buy Elevance Health Stock
Wondering how to invest in Elevance Health stock? Here's how.
- Decide where to buy Elevance Health stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Elevance Health stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your payment method and add your info.
- Research Elevance Health stock: The Elevance Health ticker symbol is ELV. Is Elevance Health stock a good investment? Should you buy shares of ELV? How do ELV's underlying business fundamentals look? Do top analysts think Elevance Health is a good buy? Why has ELV's stock price moved recently? (Hint: Our stock market research website can help you understand if ELV is a good stock to buy).
- Execute your ELV buy order: Decide if you will purchase ELV shares at the current market price or use a limit order to purchase ELV stock at a given price.
- Get the latest news on your ELV investment: Create a watchlist to keep tabs on your position in Elevance Health stock.
Step 1: Decide where to buy Elevance Health stock
You will need a brokerage account in order to access the NYSE market and buy ELV stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal details so you are able to buy ELV stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start your new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have created your account on one of the best stock apps, you need to deposit funds:
Watch the tutorial below to see the process of transferring funds into your investment account.
Step 4: Research Elevance Health stock
After you have identified the best place to buy Elevance Health stock, it's crucial to research their stock prior to investing, so you actually understand the risk as well as the opportunity.
Elevance Health Numbers
Elevance Health Due Diligence Checks
WallStreetZen was created to help part-time investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ELV's stock page.
Is ELV stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge ELV's intrinsic value.
Using relative valuations metrics:
- ELV could be undervalued based on its P/E ratio of 16.72x, relative to Healthcare Plans industry P/E ratio of 29.93x
- ELV could be undervalued based on its P/B ratio of 1.95x, relative to Healthcare Plans industry P/B ratio of 2.57x
- ELV could be overvalued based on its PEG ratio of 1.34x
You can access more valuation research on ELV's stock here.
ELV Financials at a glance
Signs that ELV is financially healthy:
- ELV earnings of $7.64B is not enough to cover its interest payments.
- There are more short-term assets than short-term liabilities on the ELV balance sheet.
- ELV's operating cash flow of $7.61B allows it to safely service it's debt of $31.84B.
- There are more short-term assets than long-term liabilities on the ELV balance sheet.
Signs that ELV is not financially healthy:
- Total ELV debt is higher than 5 years ago, relative to shareholder equity.
- ELV has a relatively high debt to equity ratio of 1.86.
- ELV profit margin has gone down from 3.2% to 2.6% in the past year.
Is it a good time to buy Elevance Health stock, according to Wall Street analysts?
Out of 14 Wall Street analysts who monitor ELV, the consensus analyst rating on ELV is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent ELV Analyst Upgrades/Downgrades
Andrew Mok, a bottom 4% analyst from Barclays maintains ELV with a strong buy rating and raises their ELV price target from $408.00 to $480.00, on May 26, 2026.
A.J. Rice, a top 10% analyst from UBS maintains ELV with a strong buy rating and raises their ELV price target from $400.00 to $460.00, on May 22, 2026.
UBS's A.J. Rice raised their price target on Elevance Health (NYSE: ELV) by 15% from $400 to $460 on 2026/05/22. The analyst maintained their Strong Buy rating on the stock.
Raising their price target on Elevance Health in a post-quarterly wrap-up note on Managed Care names, Rice said the group "broadly raised guidance after stronger-than-expected results that benefited from favorable respiratory trends and seasonal cost patterns."
Looking ahead, the analyst said that improved Medicare Advantage rates, steadier ACA exchange enrollment, and modest Medicaid outperformance have boosted investor confidence in margin recovery in spite of ongoing cost pressures from specialty drugs, GLP-1s, and behavioral health.
George Hill, a top 14% analyst from Deutsche Bank upgrades ELV to a strong buy rating and raises their ELV price target from $363.00 to $498.00, on May 20, 2026.
Jason Cassorla, a top 33% analyst from Guggenheim maintains ELV with a strong buy rating and raises their ELV price target from $396.00 to $399.00, on Apr 24, 2026.
Elizabeth Anderson, a top 19% analyst from Evercore ISI Group maintains ELV with a hold rating and raises their ELV price target from $345.00 to $360.00, on Apr 23, 2026.
You can dive deeper into what analysts are saying on the Elevance Health stock forecast page.
ELV Technicals
Is ELV Making Money?
Last year, ELV earnings were $5.24B. During the past five year, ELV's earnings have gone up by 4.5% per year. This was faster than the Healthcare Plans industry average of -6.5%.
Last year, ELV revenue was $200.42B. Over the last five year, ELV's revenue has increased by 9.97% per year. This was slower than the Healthcare Plans industry average of 11.75%.
Dig into ELV's earnings and revenue performance here.
Latest Insiders Trades at ELV
In the last 12 months, insiders at ELV have sold more shares than they have bought.
Ronald W. Penczek, CAO Controller of ELV, was the latest ELV insider to sell. They sold $148,766.04 worth of ELV shares on Jun 12, 2026.
Get more info about who owns ELV shares here.
Can I rely on ELV as an income stream?
Elevance Health pays a dividend of 1.74%, compared to the Healthcare Plans industry's average dividend yield of 1.89%. If you owned $1,000 worth of ELV stock, you would have received $17.36 in the past 12 months.
Elevance Health dividend payments have consistently grown over the past decade and have remained stable.
Find more analysis about Elevance Health dividend yield and history here.
What do other investors have to say about ELV?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your ELV buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, use a limit order.
Click the Open button and your broker will execute the order.
If you need more info about buying stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your ELV investment
Now that you own some shares in ELV, you'll want to keep up with your new company.
Make a watchlist to get alerted to the latest events about your ELV stock.
ELV Feed
How to Buy Stock in Elevance Health
To reiterate, here are the 6 steps to buy stock in Elevance Health:
- Decide where to buy Elevance Health stock
- Create a brokerage account
- Fund your brokerage account
- Research Elevance Health stock
- Execute your ELV buy order
- Get the latest news on your ELV investment
If you require a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Elevance Health, create your watchlist below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.